Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Research Notes

Open Access

Pattern of neurological diseases in adult outpatient neurology clinics in tertiary care hospital

  • Safia Awan1,
  • Saad Shafqat1,
  • Ayeesha Kamran Kamal1,
  • Aziz Sonawalla1,
  • Sarwar Siddiqui1,
  • Fowzia Siddiqui1 and
  • Mohammad Wasay1, 2Email author
BMC Research Notes201710:545

https://doi.org/10.1186/s13104-017-2873-5

Received: 1 June 2017

Accepted: 24 October 2017

Published: 2 November 2017

Abstract

Objectives

The burden of neurological diseases in developing countries is rising although little is known about the epidemiology and clinical pattern of neurological disorders. The objective of this study was to understand the burden of disease faced by neurologists a in tertiary care setting.

Results

A prospective observational study was conducted of all presentations to neurology clinics at Aga Khan University Hospital Karachi over a period of 2 years. A total of 16,371 out-patients with neurological diseases were seen during the study period. The mean age of the study participants were 46.2 ± 18.3 years and 8508 (52%) were male. Headache disorders were present in 3058 (18.6%) of patients followed by vascular diseases 2842 (17.4%), nerve and root lesions 2311 (14.1%) and epilepsies 2055 (12.5%). Parkinson’s disease was more prevalent in male participants 564 (70.8%) as compared to female 257 (62.1%) (p = 0.002). Migraines and vertigo disease were more diagnosed in females as compared to males. Epilepsies were seen more in younger age groups. Parkinson’s disease was seen in 50.9% of participants between the ages of 45 and 65 years, and the frequency increased with age.

Keywords

Neurological disordersDeveloping countriesEpidemiologyClinical pattern

Introduction

Neurological disorders (NDs) are increasing because of demographic and epidemiologic changes occurring in both developed and developing countries. Neurological disorders accounted for 3.0% of global disability-adjusted life-years (DALYs); mainly due to epilepsy and migraines. While in some regions dementia was a major cause, at the global level NDs accounted for 11.3 million DALYs [1]. The overall burden of neurological disorders significantly increases among adults in low- and middle-income countries (LMICs) [2].

Regional differences in neurologic disorders and stroke related risk of death are smaller at older ages than at younger ages, ranging from around 40 to 60% in the developed countries and 70% in sub-Saharan Africa [1, 3, 4]. The Global Burden of Disease 2010 data suggests that non communicable diseases (NCDs) and injuries account for 77% of age standardized deaths in Pakistan [5].

The burden of neurological diseases in developing countries is rising and it is important to know the disease prevalence and pattern based on geographical, social, cultural, religious, and ethnic factors. A population based study conducted in India found 3355 individuals with neurological disorders per 100,000 populations. The most frequent disorders were headache, febrile convulsions, epilepsy, stroke and mental retardation [6]. A study conducted in Saudi Arabia showed that the crude prevalence of neurological disorders was 131/1000 population. Headache, epilepsy, febrile convulsions and mental retardation were common as compared to stroke, dementias and Parkinson’s disease [7].

The available information on the pattern and frequency of major neurological disorders in Pakistan is limited to hospital-based populations who may not be totally representative of the community. The incidence or prevalence of neurological diseases in Pakistan is not known [8]. However the Global Burden of Disease 2010 data suggests that more than half of disability due to neurological diseases is related to stroke followed by dementias, migraine, epilepsy and tetanus [9].

The estimated prevalence of people with dementia in Pakistan is around 200,000. The estimated volume of visits to neurology clinics in Pakistan is close to 200,000 visits per year. The demographics and diagnosis of these patients may vary from area to area. A data base of demographics and diagnosis of outpatients seen at neurology clinics at a tertiary care hospital not only identifies the frequency of different neurological diseases but also includes patient details such as gender and age groups. Findings from this database may open up avenues for further research, particularly in the development of community based studies and interventions/clinical trials to help improve the health of the population.

Aims and objectives

The overall aim of the study was to generate knowledge about neurological disorders NDs in patients attending neurologic clinics in a low-income setting and to contribute the neglected public health field in Pakistan.

The main objective of the study was to estimate the frequency of the main NDs in outpatient neurological clinics at a tertiary care hospital in Karachi

Main text

Methods

Study design and setting

The records of all out-patients (18 years and above) seen in neurological clinics were collected at Aga Khan University (AKU) hospital from January 2014 to December 2015. A retrospective observational study was conducted of all presentations to neurology clinics over a period of 2 years. The study was approved by the Ethical Review Committee (ERC) of the Aga Khan University.

Data collection

The WHO protocol for the detection of major neurological disorders was used as the basis for the questionnaire. The questionnaire was tested and modified to suit the needs of this study. The questionnaire was designed to collect data on demographics including age, sex, place and type of residence (rural/urban), referral and patient’s evaluation status (new versus follow-up patient). A diagnosis as a referenced neurology case was determined by neurologist after conducting a physical examination of the patient. The main types of NDs along with sub-group were offered in the questionnaire to record the exact neurological disorder [10].

Uniform and standard criteria was used by neurologists for the diagnosis of cases. For each disorder, WHO classifications and definitions were used to assess the neurological disorder as follows. (1) Vascular diseases, (2) CNS infections, (3) demyelinating diseases, (4) movement disorders, (5) cerebellar ataxias and hereditary spastic paraplegias, (6) CNS neoplasms, (7) dementias, (8) epilepsies, (9) headache disorders, (10) nerve and root lesions, (11) myopathies/muscle disorders, (12) spinal disorders, (13) acquired metabolic and toxic disorders, (14) psychiatric disorders, (15) developmental disorders, and (16) neurometabolic/nutritional disorders of the nervous system.

The diagnoses were made clinically with laboratory and radiological confirmation. Radiological tests used included CT-scans (brain and spine), spine X-rays, and MRI. Electrophysiological tests included electroencephalography (EEG), electroneuromyography (ENMG), and electrocardiography (ECG).

Statistical analysis

Descriptive analysis for demographic variables was performed; results were reported as numbers with percentages for quantitative variables, and mean ± standard deviation or median with ranges for all qualitative variables. Comparison between different age groups and gender with neurological diseases were performed using Pearson Chi square test. p < 0.05 was considered as statistically significant; all p values were two sided. SPSS 19.0 (SPSS Inc., Chicago: IL, USA) was used for data entry and analysis.

Results

A total of 16,371 out-patients with neurological diseases were seen during the study period. The mean age of the study participants was 46.2 ± 18.3 years with median of 46 years. Patients over 40 years made up 8389 (51.2%) of the participants. A total of 8508 (52%) were male and 7867 (48.1%) were female.

The frequency of various neurological disorder groups is shown in Table 1. Headache disorders were present in 18.6% of patients followed by vascular diseases 17.4%, nerve and root lesions 14.1%, epilepsies 12.5%, psychiatric disorders 11.7% and neurometabolic/nutritional disorders 11.3%. Among the vascular group stroke was presented in 2792 (98.2%) of patients. The most common sub type was ischaemic stroke 2277 (81.6%) followed by haemorrhagic stroke 294 (10.5%). Migraine 1698 (55.5%) was the most common presentation amongst the headache disorder group. The most common presentation among the sleep disorders group was obstructive sleep apnoea 105/195 (53.8%) followed by restless leg syndrome 87/195 (44.6%). Among the CNS infections group, tuberculous meningitis 162 (65.3%), viral meningitis 44 (17.7%) and bacterial meningitis 32 (12.9%) were the most common presentations. The dementia group is mainly constituted of two types of diseases; Alzheimer’s 211 (45.8%) followed by dementia 207 (45%). Among movement disorders, Parkinson’s disease 821 (67.7%) was the most common presentation, followed by dystonia 141 (11.6%). Partial epilepsy with or without generalization 629 (44.9%) was the most common type of epilepsies followed by generalized epilepsy 373 (26.6%) and epilepsy 326 (23.3%). Musculoskeletal pain 1017 (58.6%) was the most common presentation of myopathies. Vertigo was seen in 510 (3.11%) patients followed by Bell’s palsy 161 (0.98%). The frequency of the top neurological diseases seen in out-patient clinics are presented in Fig. 1. The frequencies of neurological diseases in patients above the age of 45 years are presented in Additional file 1. The prevalence of stroke was similar in both genders. Parkinson’s disease was more prevalent in males 564 (70.8%) than females 257 (62.1%); (p = 0.002). Epilepsies were seen more in males 737 (71.3%) as compared to females 665 (65.1%); (p = 0.003). Migraines 1231 (60.7%) versus 467 (45.4%) and vertigo disease 260 (61.6%) versus 249 (49.7%) were more common in females as compared to males; Table 2. Of the Parkinson’s disease patients 50.9% were between the ages of 45 and 65 years. A comparison of different disease and age groups is shown in Additional file 2.
Table 1

Diagnosis profile of the study population n = 16,371

Diagnosis

n

%

Vascular disease

2842

17.4

Stroke

2792/2842

98.2

Types (n = 2729)

  

 Ischaemic stroke

2277

81.6

 Transient stroke

170

6.1

 Haemorrhagic stroke

294

10.5

 Ischemia and hemorrhagic

19

0.7

 Ischemia and transient

30

1.1

 Transient and hemorrhage

2

0.1

Cerebellar ataxias and hereditary spastic paraplegias

311

1.9

Motor neuron diseases

60

19.2

Sleep disorders

195

 

Restless leg syndrome

87

44.6

Obstructive sleep apnoea

105

53.8

Headache disorders

3058

18.6

Type of headache (n = 1370)

  

 Headache disorder

651

21.2

 Tension type headache

574

18.7

 Cluster headache

29

0.68

 Chronic headache

28

2.04

 Headache due to psychiatric disorder

26

1.89

 Headache attributed to head and/or neck trauma

11

0.35

Migraine

1698/3058

55.5

Acquire metabolic and toxic disorders

13

0.07

CNS infection

314

0.01

Meningitis (n = 248)

  

Bacterial meningitis

32

12.9

Tuberculous meningitis/tuberculoma

162

65.3

Fungal meningitis

6

2.4

Viral meningitis

44

17.7

Symptomatic meningitis

4

1.6

CNS neoplasm

151

0.92

Meningioma

27

17.8

Oligodendroglioma

23

15.2

Pituitary adenoma

20

13.2

Glioma

15

9.9

Nerve and root lesion

2311

14.1

Cervical radiculopathy

369

15.9

Carpal tunnel syndrome

153

6.6

Diabetic polyneuropathy

129

5.5

Guillain–Barre syndrome(AIDP)

94

4.0

Psychiatric disorders

1916

11.7

Depression

1486

77.5

Anxiety

188

9.8

Conversion disorders

86

4.4

Demyelinating diseases

181

1.10

Multiple sclerosis

121/181

6.6

Dementias

460

2.8

Alzheimer’s diseases

211

45.8

Dementia frontal/vascular

207

45

Myopathies/muscle disorders

1734

10.5

Musculoskeletal pain

1017

58.6

Myasthenia gravis

190

10.9

Fibromyalgia

193

11.1

Myopathies/muscle disorders

49

2.8

Neck strain

39

2.2

Polymyositis

33

1.9

Development disorders

81

0.49

Mental retardation

19

23.4

Movement disorders

1211

7.3

Parkinson’s diseases

821

67.7

Dystonias

141

11.6

Essential tremor

89

7.3

Epilepsies

2055

12.5

Epilepsy

326

23.3

Partial epilepsy with or without generalization

629

44.9

Generalised epilepsy

373

26.6

Juvenile myoconic epilepsy

55

3.9

Seizures

591

28.7

Febrile seizures

7

1.2

Seizures vs. Pseudoseizures

13

2.2

Fits

91

15.4

Complex partial seizures

3

0.5

Seizures

439

74.3

GTC (general tonic chronic seizures)

16

2.7

Pseudoseizures

12

2.7

 Non-epileptic seizures

2

2.0

 Post traumatic seizures

3

0.5

 Systematic seizures

1

0.2

 Neonate seizure

1

0.2

 Focal seizures

2

0.3

 Syncopy vs. seizures

1

0.2

Spinal disorders

124

0.75

Myelitis

62

50

Myelopathy

62

50

Others

  

Bell palsy

161

0.98

Vertigo

510

3.11

Encephalopathy

33

0.20

Neurometabolic/nutritional

174

1.06

Vitamin D deficiency osteomalacic

72

41.3

B12 deficiency

80

45.9

Wilson disease

22

12.6

Fig. 1

The ten leading diseases in the out-patients neurology clinics

Table 2

Distribution of diagnosis among male and females

 

Male, n (%)

Female, n (%)

p value

Stroke, n = 2792

1795 (98.6)

997 (97.6)

0.052

Meningitis, n = 248

127 (78.4)

121 (80.1)

0.78

Parkinson’s disease, n = 821

564 (70.8)

257 (62.1)

0.002

Epilepsy, n = 1402

737 (71.3)

665 (65.1)

0.003

Musculoskeletal pain, n = 1017

471 (59.1)

546 (58.3)

0.73

Migraine, n = 1698

467 (45.4)

1231 (60.7)

< 0.001

Vertigo, n = 510

249 (49.7)

260 (61.6)

< 0.001

Alzheimer’s, n = 211

106 (43.8)

105 (48.2)

0.35

Dementia, n = 207

104 (43)

103 (47.2)

0.39

Obstructive sleep apnoea, n = 105

60 (33.3)

45 (34.4)

0.90

Discussion

The study was designed to investigate the frequency of NDs in Pakistan. NDs commonly cause public health challenges, creating burdens and disability.

In our study, the age group between 46 and 65 years represented 34% of all out-patient visits. A study from Dhaka, Bangladesh reported 59.7% of admissions in neurology were after the age of 40 years [11]. A study from Nigeria reported 40.8% were aged between 51 and 60 years [12]. The mean age of the study participants was 46 years which was similar to the mean age reported in other studies done in Pakistan [13], Bangladesh [11] and African countries [1416]. Most patients were self-referrals and the leading diagnosis in our study were headache, stroke, epilepsies, depression, musculoskeletal pain, Parkinson’s, vertigo, cervical radiculopathy, dementia and meningitis. The leading cause of headache disorders is similar to the study by Alam et al. conducted in Peshawar, Pakistan [13], Anand et al. from India [17], and Callixte et al. from sub-Saharan Africa [16, 18].

The most common cause of out-patient visits was stroke (98.2%), which is similar to previous studies [11, 12, 14, 16, 19]. According to WHO estimates in 2001, 86% of deaths related to stroke worldwide occurred in developing countries [20].

A population-based study [21] from Pakistan showed a much higher prevalence of stroke 19,000 per 100,000 population (19·1%) in comparison with worldwide literature. A study from India estimates the prevalence of stroke ranges from 44 to 843 per 100,000 population [22]. Further studies are needed to determine the prevalence of stroke subtypes between Pakistani and Western populations [23]. Furthermore, meningitis was the second leading cause of out-patient clinic visit in our study. A prior study reported headache as the most common presentation, followed by cerebrovascular accidents and epilepsy [13]. A study from Bangladesh reported that stroke and seizures were the most seen diagnosis [11]. Other than meningitis, epilepsy was the most common neurological disorder and the highest prevalence is seen in people under 30 years of age [24]. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological disorders [25].

Neurodegenerative diseases are frequent in older populations. Meta-analysis of worldwide data showed the prevalence of Parkinson’s disease rising with age. An estimated 7 to 10 million people are living with Parkinson’s disease [26]. Prevalence differed by geographic location [27], however, dementia was seen both in young and older age groups [28]. The prevalence of dementia in South Asia is estimated to be 1.9% [29]. Alzheimer’s disease is responsible for 45.8% of admissions in our neurological setting.

Mental illnesses in Pakistan depicts a gloomy picture with a 6% prevalence of depression, 1.5% schizophrenia, 1–2% epilepsy and 1% of Alzheimer’s disease [30]. Due to a lack of research, it is difficult to get an accurate number of people suffering from these diseases.

Pakistan’s estimated population is over 194.9 million, making it one of the world’s most-populous countries. At least 10% of the population of Pakistan suffers from neurological diseases. More than 70% of medical colleges and almost 75% of government hospitals are without neurologists. Pakistan produces 10–20 neurologists annually out of which 50% leave the country. The present study lays a foundation of data regarding ND burden in this region to build a registry of data and address the gap in existing information about this neglected area of disease epidemiology.

Limitation

We had some limitations in this study. First, this study is a hospital-based design and patients were seen only once by the neurologist so follow up data was unavailable. Second, this study was conducted in an urban centre so the data is not necessarily representative of the whole country. Further studies involving large cohorts are required to validate these findings in both urban and rural populations.

Abbreviations

NDs: 

neurological disorders

DALYs: 

disability-adjusted life-years

ECG: 

electrocardiography

Declarations

Authors’ contributions

MW developed the idea. SA wrote the manuscript and performed the statistical analysis. SS1 drafting the manuscript. AKK and SS2: review of final manuscript. AzS: development and testing of the instrument. FS: development of the instrument. All authors contributed to check the final diagnosis of each patient, the literature review, and the review of the final draft. All authors read and approved the final manuscript.

Acknowledgements

We acknowledge our team of data collectors for their hard work and dedication.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

The datasets analysed during the current study are provided within the manuscript. The SPSS data file used during the current study are available in Additional file 3.

Consent to publish

Not applicable.

Ethics approval and consent to participate

The study was approved by the Ethical Review Committee (ERC) of the Aga Khan University.

All data used in this study is publicly available. No effort is made by the authors to determine the identity of any cases, or to use the information for any purpose other than for statistical reporting and analysis.

Funding

The authors were partially supported by Departmental Research funds.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Section of Neurology, Department of Medicine, Aga Khan University Hospital Karachi
(2)
Department of Neurology, Aga Khan University

References

  1. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.View ArticlePubMedGoogle Scholar
  2. Birbeck GL, Meyer A-C, Ogunniyi A. Nervous system disorders across the life course in resource-limited settings. Nature. 2015;527(7578):S167–71.View ArticlePubMedGoogle Scholar
  3. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease and Risk Factors. Washington (DC): World Bank; 2006.Google Scholar
  4. Chin JH, Vora N. The global burden of neurologic diseases. Neurology. 2014;83(4):349–51.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380(9859):2095–128.View ArticleGoogle Scholar
  6. Gourie-Devi M, Gururaj G, Satishchandra P, Subbakrishna DK. Prevalence of neurological disorders in Bangalore, India: a community-based study with a comparison between urban and rural areas. Neuroepidemiology. 2004;23(6):261–8.View ArticlePubMedGoogle Scholar
  7. Al Rajeh S, Bademosi O, Ismail H, Awada A, Dawodu A, Al-Freihi H, Assuhaimi S, Borollosi M, Al-Shammasi S. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology. 1993;12(3):164–78.View ArticlePubMedGoogle Scholar
  8. Wasay M. Neurological care in Pakistan: actions are needed. J Pak Med Assoc. 2003;53(12):576.PubMedGoogle Scholar
  9. World Health Organization. Neurological disorders: public health challenges. Geneva: World Health Organization, 2006.Google Scholar
  10. World Health Organization. International statistical classification of diseases and related health problems. 2009.Google Scholar
  11. Chowdhury RN, Hasan ATMH, Rahman YU, Khan SI, Hussain AR, Ahsan S. Pattern of neurological disease seen among patients admitted in tertiary care hospital. BMC Res Notes. 2014;7(1):1.View ArticleGoogle Scholar
  12. Owolabi LF, Shehu MY, Shehu MN, Fadare J. Pattern of neurological admissions in the tropics: experience at Kano, Northwestern Nigeria. Ann Indian Acad Neurol. 2010;13(3):167.View ArticlePubMedPubMed CentralGoogle Scholar
  13. M Alam S, Khan H, Wahid K. Spectrum of neurological disorders presenting at a neurology clinic in tertiary care hospital in Peshawar, Pakistan. Pak J Neurol Sci. 2015;10(4):23–6.Google Scholar
  14. Ojini FI, Danesi MA. The pattern of neurological admissions at the Lagos University Teaching Hospital. Niger J Clin Pract. 2003;6(1):38–41.Google Scholar
  15. Eze CO, Kalu UA. Pattern of neurological admissions in the tropics: experience at Abakaliki South-Eastern Nigeria. Niger J Med. 2014;23(4):302–5.Google Scholar
  16. Tegueu CK, Nguefack S, Doumbe J, Fogang YF, Mbonda PC, Mbonda E. The spectrum of neurological disorders presenting at a neurology clinic in Yaoundé, Cameroon. Pan Afr Med J. 2013;14:148. doi:10.11604/pamj.2013.14.148.2330.
  17. Anand KS, Singh MMC, Chandra SMM. Pattern of neurological disorders above the middle aged population in JIPMER, Pondicherry. Neurol India. 1993;41(3):157.Google Scholar
  18. Callixte K-T, Clet TB, Jacques D, Faustin Y, François DJ, Maturin T-T. The pattern of neurological diseases in elderly people in outpatient consultations in sub-Saharan Africa. BMC Res Notes. 2015;8(1):1.View ArticleGoogle Scholar
  19. Gajurel BP, Parajuli P, Nepali R, Oli KK. Spectrum of neurological disorders admitted in Tribhuvan University Teaching Hospital Maharajgunj. J Inst Med. 2012;34:50–3.Google Scholar
  20. Khealani BA, Hameed B, Mapari UU. Stroke in Pakistan. J Pak Med Assoc. 2008;58(7):400.PubMedGoogle Scholar
  21. Kamal AK, Itrat A, Murtaza M, Khan M, Rasheed A, Ali A, Akber A, Akber Z, Iqbal N, Shoukat S. The burden of stroke and transient ischemic attack in Pakistan: a community-based prevalence study. BMC Neurol. 2009;9(1):1.View ArticleGoogle Scholar
  22. Prasad K, Vibha D. Cerebrovascular disease in South Asia—Part I: a burning problem. JRSM cardiovasc Dis. 2012;1(7):20.Google Scholar
  23. Wasay M, Khatri IA, Kaul S. Stroke in South Asian countries. Nature Rev Neurol. 2014;10(3):135.View ArticleGoogle Scholar
  24. Khatri IA, Iannaccone ST, Ilyas MS, Abdullah M, Saleem S. Epidemiology of epilepsy in Pakistan: review of literature. JPMA. 2003;53(12):594–7.Google Scholar
  25. World Health Organization. Epilepsy—fact sheet. Geneva: World Health Organization; 2016.Google Scholar
  26. (PDF) PsDF. Statistics on Parkinson’s. 2016.Google Scholar
  27. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson’s disease: a systematic review and metaâ analysis. Mov Disord. 2014;29(13):1583–9.View ArticlePubMedGoogle Scholar
  28. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer’s Dement. 2013;9(1):63–75.View ArticleGoogle Scholar
  29. Ahmad A, Owais K, Siddiqui M, Mamun K, Rao F, Yousufzai AW. Dementia in Pakistan: national guidelines for clinicians. Pak J Neurol Sci (PJNS). 2013;8(3):17–27.Google Scholar
  30. Gadit AAM, Vahidy A. Mental health morbidity pattern in Pakistan. J Coll Physicians Surg Pak. 1999;9:362–5.Google Scholar

Copyright

© The Author(s) 2017

Advertisement